We are delighted to share a collection of highly viewed papers on cancer biomarkers that were published in Cancers (ISSN: 2072-6694) in the first half of 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:

The list of relevant papers can be seen below:

“Artificial Intelligence-Assisted Drug and Biomarker Discovery for Glioblastoma: A Scoping Review of the Literature”
by Luana Conte, Gerardo Caruso, Anil K. Philip, Federico Cucci, Giorgio De Nunzio, Donato Cascio and Maria Caffo
Cancers 2025, 17(4), 571; https://doi.org/10.3390/cancers17040571
Available online: https://www.mdpi.com/2072-6694/17/4/571

“Exosome-Mediated Cellular Communication in the Tumor Microenvironment Imparts Drug Resistance in Breast Cancer”
by RamaRao Malla, Priyamvada Bhamidipati, Anuveda Sree Samudrala, Yerusha Nuthalapati, Vasudevaraju Padmaraju, Aditya Malhotra, Annah S. Rolig and Sanjay V. Malhotra
Cancers 2025, 17(7), 1167; https://doi.org/10.3390/cancers17071167
Available online: https://www.mdpi.com/2072-6694/17/7/1167

“Novel Urinary Biomarkers for the Detection of Bladder Cancer”
by Matthijs Oyaert, Charles Van Praet, Charlotte Delrue and Marijn M. Speeckaert
Cancers 2025, 17(8), 1283; https://doi.org/10.3390/cancers17081283
Available online: https://www.mdpi.com/2072-6694/17/8/1283

“Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted Therapies”
by Eduarda Carvalho, Sule Canberk, Fernando Schmitt and Nuno Vale
Cancers 2025, 17(7), 1102; https://doi.org/10.3390/cancers17071102  
Available online: https://www.mdpi.com/2072-6694/17/7/1102

“The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors”
by Murad Guliyev, Ali Kaan Güren, Emre Özge, Rumeysa Çolak, Nargiz Majidova, Gülin Alkan Şen, Shamkhal Safarov, Murat Günaltılı, Mehmet Cem Fidan, İlkay Gültürk et al.
Cancers 2025, 17(4), 693; https://doi.org/10.3390/cancers17040693  
Available online: https://www.mdpi.com/2072-6694/17/4/693

“Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence”
by Rafi Kabarriti, Shane Lloyd, James Jabalee, Catherine Del Vecchio Fitz, Randa Tao, Tyler Slater, Corbin Jacobs, Sean Inocencio, Michael Rutenberg, Chance Matthiesen et al.
Cancers 2025, 17(2), 174; https://doi.org/10.3390/cancers17020174  
Available online: https://www.mdpi.com/2072-6694/17/2/174

Special Issues:

“Biomarkers for Gynecological Cancers”
Guest Editor: Dr. Apriliana Kartikasari
Submission deadline: 31 March 2026

“Predictive Biomarkers for Lung Cancer”
Guest Editor: Prof. Dr. Ole Hilberg
Submission deadline: 30 December 2025

“Biomarkers for Therapy Response in Gastrointestinal Malignancies: Predicting Outcomes and Personalizing Care”
Guest Editor: Dr. Devalingam Mahalingam
Submission deadline: 30 April 2026

“MicroRNA in Cancer: From Molecular Mechanisms to Therapeutic Applications”
Guest Editors: Prof. Dr. Girish Shukla and Dr. Sivakumar Vijayaraghavalu
Submission deadline: 31 May 2026

You can view and submit relevant papers to Cancers via the following link: https://www.mdpi.com/journal/cancers.